[Placebo-controlled study of melbrosia in treatment of climacteric symptoms].
In a placebo controlled randomized trial we evaluated the efficacy of melbrosia in women who suffered from severe menopausal symptoms. We could show that there was hardly no difference in the change of biochemical parameters, but we found out that the decrease of menopausal symptoms (headache, urinary incontinence, dry vagina, decreasing vitality) was significant in women who did undergo melbrosia medication compared to those who just took placebo. Due to our investigations we reasoned that melbrosia is especially appropriate to women who do not want and who do not need hormone replacement therapy, but who do suffer from menopausal symptoms.
Szanto
E
E
Ambulatorium für Diagnostik und Therapie des klimakterischen Syndroms, MENOX, Wien.
Gruber
D
D
Sator
M
M
Knogler
W
W
Huber
J C
JC
D000328:Adult; D000818:Animals; D001516:Bees; D015519:Bone Density / Q000187:drug effects; D002979:Climacteric / Q000097:blood / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005227:Fatty Acids / Q000627:therapeutic use*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D008875:Middle Aged; D011058:Pollen; D011446:Prospective Studies; D000099219:Royal Jelly
D005227:Fatty Acids; D012739:Gonadal Steroid Hormones; D000099219:Royal Jelly
Plazebokontrollierte Untersuchung von Melbrosia zur Behandlung klimakterischer Beschwerden.